Data updated through July 2024
Similar Posts
FDA In Brief: FDA issues draft guidance to foster oncology product development for pediatric populations
FDA issues draft guidance document, “FDARA Implementation Guidance for Pediatric Studies of Molecularly Targeted Oncology Drugs: Amendments to Sec. 505B of the FD&C Act.” The draft guidance addresses early planning for pediatric evaluation of certain molecularly targeted oncology drugs.Natural MiracleZEN GOLD 60000 contains hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use Natural MiracleZEN GOLD 60000, a product promoted and sold for sexual enhancement on various websites and possibly in some retail stores.Generic Drug Facilities, Sites and Organization Lists
Generic Drug Facilities, Sites and Organization ListsMedia Networks Sydney Pty Limited – 687044 – 09/18/2024
Failure to Register and ListRecall Alert: Max Mobility/Permobil Removes All SpeedControl Dials Used with SmartDrive MX2+ Power Assist Devices
SpeedControl Dials used with SmartDrive MX2+ Power Assist Devices may be unresponsive to users and fail to stop or start unexpectedly, causing injuryFDA Approves First Over-the-Counter Naloxone Nasal Spray
The U.S. Food and Drug Administration approved the first naloxone nasal spray product available without a prescription.